63031-38-9

Upstream product

• 3457-48-5 1,2-di(4-methylphenyl)-1,2-ethanedione 
• 44387-06-6 methyl hydrazinecarbimidothioate 
• 74-88-4 methyl iodide 
• 63031-39-0 5,6-di-p-tolyl-1,2,4-triazine-3-thiol 
• 79-19-6 thiosemicarbazide 
• 35600-34-1 S-methyl isothiosemicarbazide hydroiodide 

Downstream Products

• 63074-37-3 3-methoxy-5,6-ditolyl-1,2,4-triazine 
• 74930-09-9 3-Methylsulfanyl-5,6-di-p-tolyl-2,5-dihydro-[1,2,4]triazine 
• 88300-38-3 1-[5,6-bis(4-methylphenyl)-1,2,4-triazin-3-yl]-4-piperidinol, carbamate (ester) 
• 88300-43-0 1-[5,6-bis(4-methylphenyl)-1,2,4-triazin-3-yl]-4-piperidinol, formate (ester) 
• 87186-60-5 1-[5,6-bis(4-methylphenyl)-1,2,4-triazin-3-yl]-4-piperidinol 
• 74930-24-8 (1S,3aR,6R,6aR)-1-Methyl-6a-methylsulfanyl-3,6-di-p-tolyl-6,6a-dihydro-1H-pyrrolo[3,4-c]pyrazole-3a,4-dicarboxylic acid dimethyl ester 
• 74930-25-9 (1S,3aS,6R,6aR)-6a-Methoxy-1-methyl-3,6-di-p-tolyl-6,6a-dihydro-1H-pyrrolo[3,4-c]pyrazole-3a,4-dicarboxylic acid dimethyl ester 
• 74930-16-8 (S)-2-Methyl-3-methylsulfanyl-5,6-di-p-tolyl-2,5-dihydro-[1,2,4]triazine 
• 74930-17-9 (S)-3-Methoxy-2-methyl-5,6-di-p-tolyl-2,5-dihydro-[1,2,4]triazine 
• 74930-30-6 2-methyl-3-oxo-4,8-ditolyl-6,7-bis(methoxycarbonyl)-1,2,5-triazabicyclo<4.2.0>octa-7-ene 
• 74930-10-2 3-Methoxy-5,6-di-p-tolyl-2,5-dihydro-[1,2,4]triazine 

Relevant academic research and scientific papers

Design, green synthesis and pharmacological evaluation of novel 5,6-diaryl-1,2,4-triazines bearing 3-morpholinoethylamine moiety as potential antithrombotic agents*

The aim of this research work was to investigate a series of novel 5,6-diaryl-1,2,4-triazines (3a–3q) containing 3-morpholinoethylamine side chain, and to address their antiplatelet activity by in vitro, ex vivo and in vivo methods. All compounds were syn

Microwave-assisted synthesis and anticonvulsant activity of 5,6-bisaryl-1,2,4-triazine-3-thiolderivatives

A series of 5,6-bisaryl-1,2,4-triazine-3-thiol derivatives were synthesized through microwave-promoted chemistry by condensation of the aromatic 1,2-diketones and thiosemicarbazide in a mixed green solvent. Subsequently, S-alkylation of 1,2,4-triazine-3-t

Room-temperature ionic liquid-DMSO promoted and improved one-pot synthesis of 5,6-diaryl-1,2,4-triazines

An improved and rapid one-pot synthesis of 5,6-diarylsubstituted-1,2,4- triazines in a mixture of room-temperature ionic liquid 1,3-dibutylimidazolium bromide [Bbim]+Br- and dimethylsulfoxide (DMSO) is described without the need for

In vitro antitumor activity evaluation of some 1,2,4-triazine derivatives bearing piperazine amide moiety against breast cancer cells

A series of 1,2,4-triazine derivatives bearing piperazine amide moiety has been synthesized and investigated for their potential anticancer activities. 1-[4-(5,6-Bis(4-subtituted phenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[4-(3-substituted phenyl)pipera

Diaryl-pyrazine derivatives affecting GABA binding

This invention relates to certain amino-5,6-diarylpyrazines useful as activators of GABA and benzodiazepine binding.

1,2,4-Triazine Chemistry. 10. Dihydro-1,2,4-triazines: Structural Studies of 5,6-Diaryldihydro-1,2,4-triazines through the Reactions with Dimethyl Acetylenedicarboxylate

Sodium borohydride reduction of 3-(methylthio)-5,6-diphenyl- (1a), 3-(methylthio)-5,6-ditolyl- (1c), 3-(methylthio)-5,6-dianisyl- (1e), and 3-(methylthio)-5,6-bis(p-chlorophenyl)-1,2,4-triazine (1g) afforded the corresponding 2,5-dihydro-1,2,4-triazines (

5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents

A method of treating inflammation which utilizes topically-active 5,6-diaryl-1,2,4-triazines having the formula, STR1 wherein R is hydrogen or --(X)n R1, in which X is either O or S, n is an integer which is either 0 or 1, and R

5,6-DIARYL-1,2,4-TRIAZINES

5,6-Diaryl-1,2,4-triazines, topically-active anti-inflammatory agents, having the formula, STR1 wherein R is hydrogen or --(X)n R1, in which X is either O or S, n is an integer which is either 0 or 1, and R1 is C1/su